ChromaDex 

$7.87
36
-$0.07-0.88% Tuesday 20:00

Statistics

Day High
7.92
Day Low
7.75
52W High
9.18
52W Low
2.31
Volume
541,672
Avg. Volume
809,373
Mkt Cap
0
P/E Ratio
71.55
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.01
0.04
0.06
0.09
Expected EPS
0.07
Actual EPS
N/A

Financials

8.58%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
99.6MRevenue
8.55MNet Income

Analyst Ratings

$13.00Average Price Target
The highest estimate is 13.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CDXC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Show more...
CEO
Mr. Frank Louis Jaksch Jr.
Employees
104
Country
US

Listings

0 Comments

Share your thoughts

FAQ

What is ChromaDex stock price today?
The current price of CDXC is $7.87 USD — it has decreased by -0.88% in the past 24 hours. Watch ChromaDex stock price performance more closely on the chart.
What is ChromaDex stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange ChromaDex stocks are traded under the ticker CDXC.
What is ChromaDex revenue for the last year?
ChromaDex revenue for the last year amounts to 99.6M USD.
What is ChromaDex net income for the last year?
CDXC net income for the last year is 8.55M USD.
How many employees does ChromaDex have?
As of April 01, 2026, the company has 104 employees.
In which sector is ChromaDex located?
ChromaDex operates in the Health Care sector.
When did ChromaDex complete a stock split?
The last stock split for ChromaDex was on April 13, 2016 with a ratio of 1:3.
Where is ChromaDex headquartered?
ChromaDex is headquartered in Los Angeles, US.